» Articles » PMID: 12825759

Psychiatric and Substance Dependence Comorbidities, Sexually Transmitted Diseases, and Risk Behaviors Among Methamphetamine-dependent Gay and Bisexual Men Seeking Outpatient Drug Abuse Treatment

Overview
Specialties Pharmacology
Psychiatry
Date 2003 Jun 27
PMID 12825759
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

This article describes psychiatric and substance dependence comorbidities, lifetime rates of infectious disease, and reported high-risk sexual behaviors for methamphetamine-dependent, gay and bisexual men at entry to outpatient drug abuse treatment in Los Angeles. Participants' self-reports of high-risk sexual and drug use behaviors and of history of infectious disease status were correlated with diagnostic information from 155 Structured Clinical Interviews for the DSM-IV (SCID). A total of 82 participants met criteria for lifetime depressive disorders; 44 participants met criteria for lifetime anxiety disorders. Compared to those without psychiatric diagnoses, significant differences were observed in lifetime prevalence of sexually transmitted infections among those who have generalized anxiety disorder (higher rates of genital gonorrhea), specific phobia and major depressive disorder (higher rates of oral gonorrhea), social phobia (higher rates of syphilis) and bipolar disorder, type I (higher rates of HIV). Differences in infectious disease prevalence did not correspond to significantly different rates of high-risk sexual behaviors. Findings indicate that gay and bisexual men seeking outpatient treatment for methamphetamine dependence are likely to experience psychiatric comorbidity and to have high rates of infectious disease, including HIV, syphilis and gonorrhea.

Citing Articles

Anxiety treatment of methamphetamine-dependent patients with buprenorphine: A randomized, double-blind, clinical trial.

Ahmadi J, Bazrafshan A, Sahraian A, Jalali S, Fakhermanesh M, Hooshyari Z Tzu Chi Med J. 2023; 35(1):89-94.

PMID: 36866345 PMC: 9972937. DOI: 10.4103/tcmj.tcmj_297_21.


Physical-mental health and awareness of HIV/STIs among men who have sex with men in selected cities of India.

Pal S, Pathak P, Rahaman M BMC Public Health. 2023; 23(1):320.

PMID: 36782151 PMC: 9926782. DOI: 10.1186/s12889-023-15202-z.


"It's called overamping": experiences of overdose among people who use methamphetamine.

Harding R, Wagner K, Fiuty P, Smith K, Page K, Wagner K Harm Reduct J. 2022; 19(1):4.

PMID: 35034643 PMC: 8762891. DOI: 10.1186/s12954-022-00588-7.


Cognition during active methamphetamine use versus remission.

Huckans M, Boyd S, Moncrief G, Hantke N, Winters B, Shirley K J Clin Exp Neuropsychol. 2021; 43(6):599-610.

PMID: 34612792 PMC: 8979254. DOI: 10.1080/13803395.2021.1976734.


Systems Biology Analysis of the Antagonizing Effects of HIV-1 Tat Expression in the Brain over Transcriptional Changes Caused by Methamphetamine Sensitization.

Basova L, Kesby J, Kaul M, Semenova S, Marcondes M Viruses. 2020; 12(4).

PMID: 32283831 PMC: 7232389. DOI: 10.3390/v12040426.